Clinical and commercial leaders from GE Healthcare and Dorcy Cancer Center at St. Mary-Corwin Medical Center in Pueblo, Colorado, joined together today for a special tour to honor the Center’s continuing innovation in cancer care.

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, and affordable production of medical isotopes and cancer treatment elements, has submitted its Construction Permit application to the Nuclear Regulatory Commission (NRC). This submittal is the first formal step by SHINE in seeking an NRC permit to begin construction of its medical isotope facility in Janesville, Wisconsin.

There are currently 13.7 million cancer survivors in the U.S., and that number is expected to rise to 18 million by 2022, according to the American Association for Cancer Research’s “Annual Report on Cancer Survivorship in the United States.”

Advanced Medical Isotope Corporation (AMIC) has entered into a strategic alliance with GSG International to collaborate in the joint development of technologies for the production of medical isotopes and the marketing and distribution of related isotopes, equipment and services.

The Optima MR360 Advance and Brivo MR355 Inspire, two 1.5T MR scanners from GE Healthcare, have received 510(k) clearance.

Research published this week demonstrated MRI’s potential in two mysterious and devastating illnesses as well as ongoing concerns with inappropriate use.

The short-term prognostic benefit of myocardial perfusion scintography (MPS) is well established, and the technique also delivers long-term value up to five years after initial imaging, according to a study in the Journal of Nuclear Cardiology. 

A tablet-based testing system may soon be able to listen to a voice of an individual—a football player, for instance—and by analyzing speech patterns, determine whether the person has suffered a concussion, according to researchers at the University of Notre Dame in South Bend, Ind.